RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ESTEVE J
Collezione AOU Città della Salute di Torino

Items : 3

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug

2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial. in HemaSphere / Hemasphere. 2021 Aug 2;5(8):e617. doi: 10.1097/HS9.0000000000000617. eCollection 2021 Aug.

2021
AOU Città della Salute di Torino

Döhner H; Symeonidis A; Deeren D; Demeter J; Sanz MA; Anagnostopoulos A; Esteve J; Fiedler W; Porkka K; Kim HJ; Lee JH; Usuki K; D'Ardia S; Won Jung C; Salamero O; Horst HA; Recher C; Rousselot P; Sandhu I; Theunissen K; Thol F; Döhner K; Teleanu V; DeAngelo DJ; Naoe T; Sekeres MA; Belsack V; Ge M; Taube T; et alii...

T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in American journal of hematology / Am J Hematol. 2018 Jun;93(6):736-744. doi: 10.1002/ajh.25082. Epub 2018 Mar 23.

2018
AOU Città della Salute di Torino

Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A;